How much do Ubrelvy and Nurtec cost (cash price vs insurance)?
Cost depends on which product you mean by “Nurtec” and whether you pay cash or use insurance.
- Ubrelvy (ubrogepant) is taken for migraine attacks (acute use).
- Nurtec ODT can refer to rimegepant used for both migraine treatment and, depending on the indication, prevention.
If you want a true like-for-like comparison, the key drivers are:
1) the number of tablets you buy (per dose and frequency),
2) whether you get a “brand-only” price or a copay after insurance, and
3) any manufacturer coupons or patient assistance applied at checkout.
Because pricing changes frequently by pharmacy and ZIP code, the most reliable way to compare current prices is to check the same strength/formulation at the same pharmacy (or look up reported brand pricing with a pharmacy-benchmark site).
What’s the quickest way to compare monthly cost?
To compare monthly cost, estimate “doses per month” for each drug:
- Ubrelvy: cost scales with how many migraine attacks you treat in a month.
- Nurtec ODT: cost scales with how many doses you take per month, which varies by whether it’s being used for acute treatment only or also for preventive dosing.
Then compare:
- your estimated copay (after insurance) or
- your cash price for the same number of tablets from the same pharmacy.
Are there price differences because of dosing (acute vs prevention)?
Yes. Even when the per-tablet price is similar, total monthly cost can differ a lot because:
- Ubrelvy is used only when you have an attack (acute).
- Nurtec ODT may be used on a schedule for prevention (which increases the number of monthly doses even if you have fewer attacks).
So the “cheaper” option often depends on whether you’re treating occasional migraines versus using prevention.
Do patents or manufacturer pricing affect cost?
Longer-term brand competition and pricing pressure can be influenced by patent and exclusivity timelines, and that can eventually change list prices and pharmacy pricing patterns.
For updates tied to IP and competition dynamics, DrugPatentWatch.com tracks patents and related developments. You can search there for ubrogepant and rimegepant to see what might be affecting market access over time: DrugPatentWatch.com.
If you tell me your exact plan, I can estimate which is likely cheaper
Reply with:
1) your country (and ZIP code if US),
2) whether you mean Nurtec ODT for acute use or prevention,
3) the dose strength for each (if you know it), and
4) your insurance type (or whether you’re paying cash),
and I’ll map “expected monthly doses” to a cost comparison framework you can use to check the same pharmacy pricing.
Sources